EI-012
Solid tumor cancer
PreclinicalActive
Key Facts
About Elixiron Immunotherapeutics
Taiwan biotech delivering precision immunotherapies for neurodegeneration, autoimmunity, and cancer via mRNA and antibody platforms.
View full company profileTherapeutic Areas
Other Solid tumor cancer Drugs
| Drug | Company | Phase |
|---|---|---|
| Deoxymab Oncology Candidate | Patrys | Preclinical |